Tag: hyperCVAD

#VisualAbstract Phase I: Adding carfilzomib to HyperCVAD in patients with newly diagnosed acute lymphoblastic leukemia showed favourable safety and efficacy outcomes

byKathleen Lau

February 19, 2021

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Upper extremity pain associated with poor functional recovery post-stroke
Exenatide does not slow Parkinson’s disease progression compared to placebo
#VisualAbstract: Inebilizumab Improves Outcomes in Generalized Myasthenia Gravis

No Result

View All Result